Quality Tested Third-Party Verified Highly Purified U.S. Based Expert Support
PhysIQ PeptidesPhysIQ Peptides
Back to Shop
CJC-1295 No DAC 10mg research peptide vial

CJC-1295 No DAC

Modified Growth Hormone-Releasing Factor (1-29) (CJC-1295 without DAC)

CJC-1295 No DAC, commonly classified as Modified GRF (1-29) or tetrasubstituted GHRH (1-29), is a synthetic peptide analog representing the biologically active truncated core of endogenous growth hormone-releasing hormone. The sequence incorporates four strategic amino acid substitutions (D-Ala2, Gln8, Ala15, and Leu27) engineered to enhance resistance to dipeptidyl peptidase-4 (DPP-4) cleavage and prevent oxidative degradation while maintaining full receptor binding capability.

Unlike DAC-conjugated variants designed for continuous albumin binding, CJC-1295 No DAC does not include the maleimidopropionic acid linker. Consequently, it maintains a shorter, physiological half-life in laboratory models, allowing researchers to study natural pulsatile growth hormone and downstream IGF-1 dynamics without disrupting baseline pituitary regulatory feedback mechanisms.

In preclinical research settings, CJC-1295 No DAC is utilized to evaluate endocrine signaling, cellular proliferation, protein synthesis pathways, and metabolic kinetics, providing a controlled model for studying the mammalian somatotropic axis.

Choose how to buy

Your first order ships at the regular price. Every reship after that is 5% off. Pause, change the interval, or cancel anytime.

$72.00per vial · 10mg
Ask a Question
Third-party tested · Purity ≥99% · For laboratory research use only.
Purity
≥99%
Form
Lyophilized powder
CAS Number
863288-34-0
Molecular Formula
C152H252N44O42
Molecular Weight
3367.97 g/mol
Available sizes
10mg

Sequence

Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2

Also available in blends

Mechanism of Action

CJC-1295 No DAC functions as a selective agonist at the growth hormone-releasing hormone receptor (GHRHR) located on the plasma membrane of anterior pituitary somatotrophs. Ligand-receptor binding stimulates the Gs alpha subunit, activating adenylyl cyclase and driving an intracellular accumulation of cyclic adenosine monophosphate (cAMP). This cascades into protein kinase A (PKA) activation, opening voltage-dependent calcium channels to trigger the episodic exocytosis of endogenous growth hormone.

Due to its lack of a sustained covalent conjugate, the peptide clears within a physiological window, preserving endogenous somatostatin-mediated negative feedback loops and facilitating discrete, pulsatile secretory episodes rather than uninhibited continuous secretion.

Research Areas

  • ●Pulsatile growth hormone signaling
  • ●Pituitary somatotroph receptor kinetics
  • ●Metabolic regulation and lipid oxidation
  • ●Cellular proliferation and tissue repair
  • ●Somatotropic feedback mechanisms

Selected References

  • Teichman SL et al., J Clin Endocrinol Metab, 2006
  • Alba M et al., Am J Physiol Endocrinol Metab, 2006
  • Sackmann-Sala L et al., Growth Horm IGF Res, 2009

Related Products

Dihexa research peptide vial

Dihexa

Purity
≥99%
Size
10mg
Form
Powder
$97.00Per Unit
DSIP research peptide vial

DSIP

Purity
99%
Size
5mg
Form
Powder
$30.00Per Unit
Eloralintide research peptide vial

Eloralintide

Purity
≥99%
Size
10mg
Form
Powder
$228.00Per Unit
Epithalon research peptide vial

Epithalon

Purity
99%
Size
50mg
Form
Powder
$75.00Per Unit